CLASSIC HODGKIN LYMPHOMA
Clinical trials for CLASSIC HODGKIN LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new CLASSIC HODGKIN LYMPHOMA trials appear
Sign up with your email to follow new studies for CLASSIC HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Immunotherapy showdown: which combo best battles hodgkin lymphoma?
Disease control OngoingThis phase 3 trial tests two different immunotherapy drugs—nivolumab or brentuximab vedotin—each given with standard chemotherapy for people aged 12 and older with newly diagnosed stage III or IV Hodgkin lymphoma. The goal is to see which combination better delays the cancer from…
Matched conditions: CLASSIC HODGKIN LYMPHOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 01, 2026 15:58 UTC
-
New combo therapy aims to beat High-Risk hodgkin lymphoma in kids
Disease control OngoingThis study tests whether adding brentuximab vedotin (a drug that delivers cancer-killing substances directly to lymphoma cells) to standard chemotherapy works better than chemo alone for children and young adults with high-risk Hodgkin lymphoma. About 600 participants with stage …
Matched conditions: CLASSIC HODGKIN LYMPHOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 29, 2026 15:04 UTC
-
New hope for seniors with hodgkin lymphoma: Chemo-Free combo shows promise
Disease control OngoingThis study tests a combination of two drugs, nivolumab and brentuximab vedotin, in people aged 60 and older (or younger people who cannot take standard chemotherapy) with untreated Hodgkin lymphoma. The goal is to see how well these drugs control the cancer by helping the immune …
Matched conditions: CLASSIC HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: Academic and Community Cancer Research United • Aim: Disease control
Last updated Apr 29, 2026 15:02 UTC